OTCM
RLLVF
Market cap72mUSD
Oct 31, Last price
0.22USD
Name
Relevium Technologies Inc
Chart & performance
P/E
—
P/S
112.85
EPS
—
Div yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
%
Revenues
914k
-69.28%
Net income
-5m
L-22.55%
CFO
-128k
L-94.10%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Relevium Technologies Inc. operates within the health and wellness sector, focusing on identifying, assessing, acquiring, and managing various brands and businesses, primarily through e-commerce channels. The company distributes a range of products, including dietary supplements, nutraceuticals, sports nutrition items, and cosmeceuticals, mainly through its Bioganix online brand. It also offers dietary supplements under the LeefyLyfe label and skincare solutions marketed as the Push & Pull System. Additionally, Relevium has developed specialized lines such as Relevium Senior, aimed at older adults for inflammatory conditions affecting joints, heart, and brain, and Relevium Kids, providing nutraceuticals and oral nutritional supplements for children. Headquartered in Montreal, Canada, the company was formerly known as BIOflex Technologies Inc. until it rebranded to Relevium Technologies Inc. in December 2015.
Key people
Mark Billings
Chief Financial Officer · since 2019
President, Chief Executive Officer, Director · since 2018
Pierre Bertrand
Independent Director · since 2017
Independent Chairman of the Board · since 2015
Tina Sampalis
Independent Director · since 2017
Independent Director · since 2015
Legal address
3999 boul. de Cote-Vertu
Montreal, QC H4R 1R2
CA
Montreal, QC H4R 1R2
CA
Headquarters
1000 Sherbrooke Street
Suite 2700
Montreal, QC H3A 3G4
CA
Suite 2700
Montreal, QC H3A 3G4
CA
Valuation
Title CAD in thousands, except ratios and share amounts | FY | FY |
|---|---|---|
| 2021‑06 | 2020‑06 | |
| Income | ||
Revenues | ||
Cost of revenue | ||
Unusual Expense (Income) | ||
NOPBT | ||
NOPBT Margin | ||
Operating Taxes | ||
Tax Rate | ||
NOPAT | ||
Net income | ||
Dividends | ||
Dividend yield | ||
Proceeds from repurchase of equity | ||
BB yield | ||
| Debt | ||
Debt current | ||
Long-term debt | ||
Deferred revenue | ||
Other long-term liabilities | ||
Net debt | ||
| Cash flow | ||
Cash from operating activities | ||
CAPEX | ||
Cash from investing activities | ||
Cash from financing activities | ||
FCF | ||
| Balance | ||
Cash | ||
Long term investments | ||
Excess cash | ||
Stockholders' equity | ||
Invested Capital | ||
ROIC | ||
ROCE | ||
| EV | ||
Common stock shares outstanding | ||
Price | ||
Market cap | ||
EV | ||
EBITDA | ||
EV/EBITDA | ||
Interest | ||
Interest/NOPBT | ||